Category Archives: Gene therapy

telomeres

BioViva’s CEO Claims to Have Longer Telomeres After Gene Therapy

BioViva reported last week that the company’s CEO, Elizabeth Parrish, successfully reversed biological ageing after being treated with the biotech’s therapies. The Seattle-based company confirmed that Parrish reversed 20 years of telomere shortening thanks to an experimental gene therapy. BioViva aims to provide regenerative medicine solutions through gene and cell therapies. The company is involved in several research lines to […]

Genome Editing Cures Muscular Dystrophy in Mice

Researchers from Duke University have used the CRISPR technology to cure Duchenne muscular dystrophy in a mouse. It is the first time that the gene editing technology is successfully used to treat an adult mammalian. The study, published in the journal Science, establishes CRISPR/Cas9 as a potential therapy for the treatment of muscular dystrophy in humans. Duchenne […]

CEO Tries DIY Gene Therapy Against Aging

Elizabeth Parrish, CEO of biotech startup BioViva, declared in the website Reddit having undergone an anti-aging gene therapy in a secret location in Latin America, dodging FDA controls. The American entrepreneur claims to be experimenting on herself a treatment against what she considers a disease: aging. BioViva personnel affirms the procedure took place in mid-September in […]

CPF1 mediated gene editing in humans

CRISPR/CPF1: New Simpler CRISPR Protein May Cut Patent Fights Short

New CRISPR discovered by original CRISPR/Cas9 discovery team promises simpler and more flexible gene editing with fewer legal tangles. Broad Institute Researchers at Massachusetts Institute of Technology, the same one’s originally involved in the Cas9 discovery, combed through hundreds of bacterial CRISPR systems in the hopes of finding another natural gene editing system. They found […]

AMSBIO Expands Range of Adeno-associated Virus Services

  AMSBIO has introduced an expanded range of Adeno-associated virus (AAV) cloning and packaging services. AAV is a small (20 nm), replication-defective, nonenveloped, non-pathogenic virus which infects humans and some other primate species. Gene therapy vectors using AAV can infect both dividing and quiescent cells and stay in a non-integrative way. Clinical trials show that AAV are safe and stable. For all […]

Next Gen Seqencing Helix

Illumina Launches Helix, App Store for Genetic Analysis

Illumina announced formation of a customer focused company that seeks to provide affordable sequencing and analysis tools marketplace through third party providers at affordable costs. Formed in partnership with Warburg Pincus and Sutter Hill Ventures, with a $100 million investment, the new venture will form an umbrella under which other genetic sequencing database service providers […]

New technology to make gRNA libraries for CRISPR/Cas9

A research team from University of California at Berkeley has developed a technique that makes gene editing much easier and cheaper. Rebecca Heald has directed the work that enables making a guide RNA (gRNA) library by enzimatic processing from any DNA source, including a whole genome. The paper is accessible online in the Developmental Cell […]

crispr-cas9

A New Software to Improve CRISPR/Cas9 Targeting

Scientists from Harvard and University of California have designed an online tool to optimize CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 targeting. The researchers compared genomic DNA (gDNA) and CRISPR guide RNA libraries for more than 1400 gene loci. The library-on-library method allowed to obtained common patterns for the most active and specific guide RNAs. The […]